Were proud to expand our offerings with liraglutide. Providers may consider compounded liraglutide for patients who require a flexible titration schedule or who are not candidates for weekly GLP-1 therapies
1 This concern has not been seen with the other GLP-1 RAs
No plan for dose titration, side-effect management, or urgent support means poor oversight
As these medications grow in use, so does the importance of understanding how they work, what to expect in terms of benefits and side effects, and how lifestyle changes such as proper nutrition and regular exercise play crucial roles in achieving long-term positive health outcomes
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomized, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA